Forms of Diagnostic Material As Sources of Mirna Biomarkers in Hepatocellular Carcinoma: A Preliminary Study

References

• Ferlay J , SoerjomataramI, DikshitRet al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer136 (5), e359–e386 (2015).
   PubMed Web of Science ®Google Scholar
• Mizuguchi Y , TakizawaT, YoshidaH, UchidaE. Dysregulated miRNA in progression of hepatocellular carcinoma: a systematic review. Hepatol. Res.46 (5), 391–4062014.
   Web of Science ®Google Scholar
• Marra M , SordelliIM, LombardiAet al. Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview. J. Transl. Med.9 (1), 171 (2011).
   PubMedGoogle Scholar
• Singh AK , KumarR, PandeyAK. Hepatocellular carcinoma: causes mechanism of progression and biomarkers. Curr. Chem. Genom. Transl. Med.12, 9–26 (2018).
   PubMedGoogle Scholar
• D'Anzeo M , FaloppiL, ScartozziMet al. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. Molecules19 (5), 6393–6406 (2014).
   PubMed Web of Science ®Google Scholar
• Cortez MA , Bueso-RamosC, FerdinJ, Lopez-BeresteinG, SoodAK, CalinGA. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol.8 (8), 467–477 (2011).
   PubMed Web of Science ®Google Scholar
• Filipowicz W , BhattacharyyaSN, SonenbergN. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nat. Rev. Genet.9 (2), 102–114 (2008).
   PubMed Web of Science ®Google Scholar
• Croce CM . Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet.10 (10), 704–714 (2009).
   PubMed Web of Science ®Google Scholar
• Volinia S , CalinGA, LiuCGet al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA103 (7), 2257–2261 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang Y , XuZ, ZhangT, WangY. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. World J. Gastroenterol.21 (34), 9853–9862 (2015).
   PubMed Web of Science ®Google Scholar
• Mitchell PS , ParkinRK, KrohEMet al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA105 (30), 10513–10518 (2008).
   PubMed Web of Science ®Google Scholar
• Schmittgen T , LivakK. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc.3 (6), 1101–1108 (2008).
   PubMed Web of Science ®Google Scholar
• Xue X , ZhaoY, WangX, QinL, HuR. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma. J. Cell Biochem.120 (1), 135–142 (2018).
   PubMed Web of Science ®Google Scholar
• Zekri AN , YoussefSE, El-DesoukyEDet al. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Tumour Biol.37 (9), 12273–12286 (2016).
   PubMedGoogle Scholar
• Khairy A , HamzaI, ShakerO, YosryA. Serum miRNA panel in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma. Asian Pac. J. Cancer Prev.17 (5), 2699–2703 (2016).
   PubMedGoogle Scholar
• Bhattacharya S , SteeleR, ShrivastavaS, ChakrabortyS, Di BisceglieAM, RayRB. Serum miR-30e and miR-223 as novel noninvasive biomarkers for hepatocellular carcinoma. Am. J. Pathol.186 (2), 242–247 (2016).
   PubMed Web of Science ®Google Scholar
• Bronte F , BronteG, FanaleDet al. HepatomiRNoma: the proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma. Crit. Rev. Oncol. Hematol.97, 312–321 (2016).
   PubMed Web of Science ®Google Scholar
• Yin J , HouP, WuZ, WangT, NieY. Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma. Tumour Biol.36 (6), 4501–4507 (2015).
   PubMedGoogle Scholar
• Zhang GL , LiXY, ZhengSQ, LiuM, LiX, TangH. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res.88 (2), 169–175 (2010).
   PubMed Web of Science ®Google Scholar
• Xing TJ , JiangDF, HuangJX, XuZL. Expression and clinical significance of miR-122 and miR-29 in hepatitis B virus-related liver disease. Genet. Mol. Res.13 (3), 7912–7918 (2014).
   PubMed Web of Science ®Google Scholar
• Abdalla MA , Haj-AhmadY. Promising candidate urinary microrna biomarkers for the early detection of hepatocellular carcinoma among high-risk hepatitis C Virus Egyptian patients. J. Cancer3, 19–31 (2012).
   PubMed Web of Science ®Google Scholar
• Wang Y , YangZ, WangLet al. miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT. Biomed. Pharmacother.109, 991–999 (2019).
   PubMed Web of Science ®Google Scholar
• Pospisilova S , PazourkovaE, HorinekAet al. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection. Neoplasma63 (5), 799–808 (2016).
   PubMed Web of Science ®Google Scholar
• Xie BH , HeX, HuaRXet al. Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma. Cancer Biomark.16 (3), 405–413 (2016).
   PubMed Web of Science ®Google Scholar
• Yao J , LiangL, ZhangYet al. GNAI1 suppresses tumor cell migration and invasion and is post-transcriptionally regulated by mir-320a/c/d in hepatocellular carcinoma. Cancer Biol. Med.9 (4), 234–241 (2012).
   PubMedGoogle Scholar
• Wei W , WanjunL, HuiS, DongyueC, XinjunY, JishengZ. miR-203 inhibits proliferation of HCC cells by targeting survivin. Cell Biochem. Funct.31 (1), 82–85 (2013).
   PubMed Web of Science ®Google Scholar
• Zhang Y , ZhengL, DingYet al. MiR-20a induces cell radioresistance by activating the PTEN/PI3K/Akt signaling pathway in hepatocellular carcinoma. Int. J. Radiat. Oncol. Biol. Phys.92 (5), 1132–1140 (2015).
   PubMed Web of Science ®Google Scholar
• Wen Y , HanJ, ChenJet al. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Int. J. Cancer137 (7), 1679–1690 (2015).
   PubMed Web of Science ®Google Scholar
• Chen Y , DongX, YuD, WangX. Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Int. J. Clin. Exp. Med.8 (10), 18462–18468 (2015).
   PubMed Web of Science ®Google Scholar
• Ahmed FE , AhmedNC, VosPWet al. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Cancer Genomics Proteomics10 (20), 93–113 (2013).
   PubMedGoogle Scholar
• Yau TO , WuCW, TangCMet al. microRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer. Oncotarget7 (2), 1559–1568 (2016).
   PubMedGoogle Scholar
• Connolly EC , Van DoorslaerK, RoglerLE, RoglerCE. Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB. Mol. Cancer Res.8 (5), 691–700 (2010).
   PubMed Web of Science ®Google Scholar
• Ji J , YamashitaT, BudhuAet al. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology50 (2), 472–480 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang L , WangW, LiXet al. MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2. Int. J. Oncol.48 (6), 2425–2434 (2016).
   PubMed Web of Science ®Google Scholar
• Yuan Q , LoyaK, RaniBet al. MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration. Hepatology57 (1), 299–310 (2013).
   PubMed Web of Science ®Google Scholar
• Lu C , LiaoZ, CaiM, ZhangG. MicroRNA-320a downregulated mediates human liver cancer cell proliferation through the Wnt/β-catenin signaling pathway. Oncol. Lett.13 (2), 573–578 (2016).
   PubMed Web of Science ®Google Scholar
• Shyu YC , LeeTL, LuMJet al. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma. J. Transl. Med.14 (1), 200 (2016).
   PubMedGoogle Scholar
• Jin B , WangW, MengXXet al. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway. BMC Cancer16 (1), 863 (2016).
   PubMedGoogle Scholar
• Qiu D , ChenJ, LiuJet al. Expression of microRNA let-7a positively correlates with hepatitis B virus replication in hepatocellular carcinoma tissues. Exp. Biol. Med.242 (9), 939–944 (2017).
   Web of Science ®Google Scholar
• Yu SL , DengH, LiXH, HuangYX, XieDY, GaoZL. Expression of microRNA-155 is downregulated in peripheral blood mononuclear cells of chronic hepatitis B patients. Hepat. Mon.16 (1), e34483 (2016).
   PubMed Web of Science ®Google Scholar
• Wang WJ , LaiRT, LuJet al. Correlation between circulating miR-122 and prognosis of chronic HBV-related liver failure. J. Dig. Dis.17 (5), 334–339 (2016).
   PubMed Web of Science ®Google Scholar
• Elfil M , NegidaA. Sampling methods in clinical research; an educational review. Emergency5 (1), e52 (2017).
   PubMed Web of Science ®Google Scholar
• Zhang F , DingL, CuiLi, BarberR, DengB. Identification of long non-coding RNA-related and -coexpressed mRNA biomarkers for hepatocellular carcinoma. BMC Medical Genomics12 (Suppl. 1), 25 (2019).
   PubMedGoogle Scholar